Breaking News Instant updates and real-time market news.

MDT

Medtronic

$90.62

0.21 (0.23%)

04:55
03/26/19
03/26
04:55
03/26/19
04:55

Medtronic management to meet with UBS

Meetings to be held in Tokyo, Japan on March 26 and in Hong Kong on March 27 hosted by UBS.

  • 27

    Mar

  • 18

    May

MDT Medtronic
$90.62

0.21 (0.23%)

02/19/19
PIPR
02/19/19
NO CHANGE
PIPR
Overweight
Piper says Medtronic business momentum should keep driving shares higher
Following Medtronic's Q3 report of a top and bottom-line beat, Piper Jaffray analyst Matt O'Brien noted that the company's results have beat expectations for 5 quarters in a row, adding that he is encouraged by all of the pipeline products that are ahead. O'Brien, who believes the momentum in the business will continue driving the stock higher, reiterated an Overweight rating on Medtronic shares.
03/18/19
PIPR
03/18/19
NO CHANGE
PIPR
Piper sees minimal impact from FDA review of paclitaxel coated devices
The FDA on Friday afternoon updated healthcare providers on its review of paclitaxel coated devices, which include Medtronic's (MDT) IN.PACT DCB and Boston Scientific's (BSX) Eluvia DES, Piper Jaffray analyst Matt O'Brien tells investors in a research note. In their pooled post-approval analysis, the FDA found ~50% increased risk of crude mortality compared to control devices and will be convening a panel to analyze this issue further, adds the analyst. He points out that the FDA is also recommending providers monitor patients who have received the devices and encouraging these providers to consider alternatives where the risks may outweigh the benefits. While this data is concerning, the result is "unsurprising given that many of these patients were included in the meta-analysis," contends O'Brien. Further, experts at the ISET 2019 conference in January were unconvinced about this connection to mortality, and a poll of the several hundred interventionists in the room indicated that it is unlikely to dampen usage in the interim, he says. As such, the analyst expects the FDA impact to have a minimal impact.
03/18/19
ADAM
03/18/19
NO CHANGE
Target $215
ADAM
Buy
Edwards Lifesciences price target raised to $215 from $190 at Canaccord
Canaccord analyst Jason Mills maintained a Buy rating on Edwards Lifesciences (EW) and raised his price target to $215 from $190 after the PARTNER 3 trial delivered superiority to surgery. In a research note to investors, Mills says he thinks the data will give Edwards a definitive marketing advantage in the TAVRmarket, relative to both Medtronic (MDT) and Boston Scientific (BSX), he thinks now has a higher hurdle to clear in TAVR than pre-Phase 3 data release.
03/18/19
WELS
03/18/19
NO CHANGE
Target $202
WELS
Outperform
Edwards Lifesciences price target raised to $202 from $188 at Wells Fargo
Wells Fargo analyst Lawrence Biegelsen raised his price target for Edwards Lifesciences to $202 from $188 after the results of the company's low-risk TAVR trial was presented at the 2019 American College of Cardiology meeting. The analyst sees potential upside to his forecast given the strong low-risk results presented at ACC. Biegelsen reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

NKE

Nike

$84.55

0.3 (0.36%)

06:26
05/20/19
05/20
06:26
05/20/19
06:26
Hot Stocks
Nike adds new terms to contracts with athletes to support them during pregnancy »

Nike is adding new terms…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CDEV

Centennial Resource Development

$10.04

-0.27 (-2.62%)

06:24
05/20/19
05/20
06:24
05/20/19
06:24
Initiation
Centennial Resource Development initiated  »

Centennial Resource…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

AAL

American Airlines

$31.76

-0.68 (-2.10%)

06:24
05/20/19
05/20
06:24
05/20/19
06:24
Downgrade
American Airlines rating change  »

American Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 29

    May

  • 12

    Jun

  • 12

    Jun

MSFT

Microsoft

$128.03

-0.97 (-0.75%)

06:23
05/20/19
05/20
06:23
05/20/19
06:23
Recommendations
Microsoft analyst commentary  »

Microsoft's Azure…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

AZZ

AZZ Inc.

$45.54

-1.08 (-2.32%)

06:21
05/20/19
05/20
06:21
05/20/19
06:21
Hot Stocks
AZZ Inc. appoints Grant Thornton as accounting, audit firm »

AZZ Inc. announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

XOG

Extraction Oil & Gas

$3.97

-0.2 (-4.80%)

06:20
05/20/19
05/20
06:20
05/20/19
06:20
Initiation
Extraction Oil & Gas initiated  »

Extraction Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$42.34

0.02 (0.05%)

06:18
05/20/19
05/20
06:18
05/20/19
06:18
Periodicals
BP ramped up Arctic drilling campaign after Trump's election, Guardian reports »

BP ramped up its campaign…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

DAL

Delta Air Lines

06:18
05/20/19
05/20
06:18
05/20/19
06:18
Downgrade
Delta Air Lines rating change  »

Delta Air Lines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 12

    Jun

  • 20

    Jun

SRCI

SRC Energy

$5.46

-0.06 (-1.09%)

06:18
05/20/19
05/20
06:18
05/20/19
06:18
Initiation
SRC Energy initiated  »

SRC Energy resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDCE

PDC Energy

$36.67

-0.55 (-1.48%)

06:16
05/20/19
05/20
06:16
05/20/19
06:16
Initiation
PDC Energy initiated  »

PDC Energy resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

UAL

United Continental

$81.52

-1.07 (-1.30%)

06:15
05/20/19
05/20
06:15
05/20/19
06:15
Upgrade
United Continental rating change  »

United Continental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 29

    May

KEYS

Keysight Technologies

$81.88

-3.33 (-3.91%)

06:14
05/20/19
05/20
06:14
05/20/19
06:14
Downgrade
Keysight Technologies rating change  »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

CRZO

Carrizo Oil & Gas

$12.92

-0.07 (-0.54%)

06:13
05/20/19
05/20
06:13
05/20/19
06:13
Initiation
Carrizo Oil & Gas initiated  »

Carrizo Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DISH

Dish

$35.33

0.27 (0.77%)

, SATS

EchoStar

$40.42

-0.21 (-0.52%)

06:13
05/20/19
05/20
06:13
05/20/19
06:13
Hot Stocks
Dish to acquire EchoStar BSS Business in all-stock transaction valued at $800M »

Dish (DISH) and EchoStar…

DISH

Dish

$35.33

0.27 (0.77%)

SATS

EchoStar

$40.42

-0.21 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MO

Altria Group

$52.34

0.19 (0.36%)

06:11
05/20/19
05/20
06:11
05/20/19
06:11
Periodicals
Capital Re buys Juul shares valuing company over $38B, NY Post reports »

Capital Re has purchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AACAY

AAC Technologies

$0.00

(0.00%)

06:10
05/20/19
05/20
06:10
05/20/19
06:10
Upgrade
AAC Technologies rating change  »

AAC Technologies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTES

NetEase

$266.54

-12.69 (-4.54%)

, DIS

Disney

$135.04

-0.46 (-0.34%)

06:10
05/20/19
05/20
06:10
05/20/19
06:10
Hot Stocks
NetEase enters strategic partnership with Marvel Entertainment »

NetEase (NTES) and Marvel…

NTES

NetEase

$266.54

-12.69 (-4.54%)

DIS

Disney

$135.04

-0.46 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    Jun

LH

LabCorp

$164.45

-0.5 (-0.30%)

, DGX

Quest Diagnostics

$97.24

0.76 (0.79%)

06:10
05/20/19
05/20
06:10
05/20/19
06:10
Recommendations
LabCorp, Quest Diagnostics, UnitedHealth analyst commentary  »

LabCorp price target…

LH

LabCorp

$164.45

-0.5 (-0.30%)

DGX

Quest Diagnostics

$97.24

0.76 (0.79%)

UNH

UnitedHealth

$241.42

4.15 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 23

    Jun

LPX

Louisiana-Pacific

$23.88

-0.29 (-1.20%)

06:09
05/20/19
05/20
06:09
05/20/19
06:09
Upgrade
Louisiana-Pacific rating change  »

Louisiana-Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

RDY

Dr. Reddy's

$39.31

-0.86 (-2.14%)

06:09
05/20/19
05/20
06:09
05/20/19
06:09
Downgrade
Dr. Reddy's rating change  »

Dr. Reddy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JACK

Jack in the Box

$82.22

3.27 (4.14%)

06:09
05/20/19
05/20
06:09
05/20/19
06:09
Upgrade
Jack in the Box rating change  »

Jack in the Box upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 27

    Jun

  • 08

    Aug

TGT

Target

$70.88

-0.06 (-0.08%)

06:09
05/20/19
05/20
06:09
05/20/19
06:09
Upgrade
Target rating change  »

Target upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 12

    Jun

MIK

Michaels

$10.46

-0.145 (-1.37%)

06:08
05/20/19
05/20
06:08
05/20/19
06:08
Downgrade
Michaels rating change  »

Michaels downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

SATS

EchoStar

$40.42

-0.21 (-0.52%)

, DISH

Dish

$35.33

0.27 (0.77%)

06:08
05/20/19
05/20
06:08
05/20/19
06:08
Hot Stocks
EchoStar announces agreement to transfer BSS Business to Dish »

EchoStar (SATS) announced…

SATS

EchoStar

$40.42

-0.21 (-0.52%)

DISH

Dish

$35.33

0.27 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$76.65

-0.18 (-0.23%)

06:08
05/20/19
05/20
06:08
05/20/19
06:08
Downgrade
Prologis rating change  »

Prologis downgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.